NCT02397603View on ClinicalTrials.gov

Peri-neural Dexmedetomidine as an Adjuvant to Bupivacaine Induced Paravertebral Block in Patients Undergonig Thoracotomy

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Acute Post-thoracotomy Pain
Interventions
DRUG

dexmedetomidine bupivacaine

perineural dexmedetomidine as an adjuvant to bupivacaine induced thoracic paravertebral block

DRUG

Bupivacaine saline

perineural bupivacaine saline mixture in the thoracic paravertebral catheter

Trial Locations (1)

Unknown

Kasr Alainy Hospital Cairo University, Giza

All Listed Sponsors
lead

Cairo University

OTHER

NCT02397603 - Peri-neural Dexmedetomidine as an Adjuvant to Bupivacaine Induced Paravertebral Block in Patients Undergonig Thoracotomy | Biotech Hunter | Biotech Hunter